PNC Financial Services Group’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,677
| Closed | -$15K | – | 4166 |
|
|
2020
Q3 | $15K | Sell |
1,677
-53
| -3% | -$504 | ﹤0.01% | 3370 |
|
|
2020
Q2 | $13K | Sell |
1,730
-613
| -26% | -$4.69K | ﹤0.01% | 3395 |
|
|
2020
Q1 | $14K | Buy |
2,343
+68
| +3% | +$599 | ﹤0.01% | 3294 |
|
|
2019
Q4 | $27K | Buy |
2,275
+214
| +10% | +$2.34K | ﹤0.01% | 3208 |
|
|
2019
Q3 | $23K | Buy |
2,061
+1,053
| +104% | +$11.1K | ﹤0.01% | 3294 |
|
|
2019
Q2 | $10K | Sell |
1,008
-48
| -5% | -$518 | ﹤0.01% | 3576 |
|
|
2019
Q1 | $14K | Sell |
1,056
-656
| -38% | -$9.77K | ﹤0.01% | 3510 |
|
|
2018
Q4 | $27K | Buy |
1,712
+133
| +8% | +$2.53K | ﹤0.01% | 3183 |
|
|
2018
Q3 | $32K | Sell |
1,579
-158
| -9% | -$3.6K | ﹤0.01% | 3251 |
|
|
2018
Q2 | $34K | Sell |
1,737
-23,915
| -93% | -$529K | ﹤0.01% | 3234 |
|
|
2018
Q1 | $518K | Buy |
25,652
+12,491
| +95% | +$211K | ﹤0.01% | 1607 |
|
|
2017
Q4 | $174K | Buy |
13,161
+403
| +3% | +$6.08K | ﹤0.01% | 2270 |
|
|
2017
Q3 | $235K | Sell |
12,758
-6,008
| -32% | -$112K | ﹤0.01% | 2065 |
|
|
2017
Q2 | $346K | Buy |
18,766
+486
| +3% | +$9.63K | ﹤0.01% | 1809 |
|
|
2017
Q1 | $412K | Buy |
18,280
+10,759
| +143% | +$258K | ﹤0.01% | 1732 |
|
|
2016
Q4 | $261K | Buy |
7,521
+7,513
| +93,913% | +$224K | ﹤0.01% | 1973 |
|
|
2016
Q3 | $0 | Sell |
8
-215
| -96% | -$5.37K | ﹤0.01% | 4412 |
|
|
2016
Q2 | $5K | Sell |
223
-4,840
| -96% | -$111K | ﹤0.01% | 3867 |
|
|
2016
Q1 | $119K | Sell |
5,063
-5,639
| -53% | -$134K | ﹤0.01% | 2401 |
|
|
2015
Q4 | $323K | Sell |
10,702
-1,374
| -11% | -$44.4K | ﹤0.01% | 1775 |
|
|
2015
Q3 | $480K | Sell |
12,076
-1,574
| -12% | -$97.7K | ﹤0.01% | 1587 |
|
|
2015
Q2 | $943K | Buy |
13,650
+748
| +6% | +$47.1K | ﹤0.01% | 1300 |
|
|
2015
Q1 | $705K | Buy |
12,902
+1,602
| +14% | +$76.4K | ﹤0.01% | 1422 |
|
|
2014
Q4 | $481K | Sell |
11,300
-1,640
| -13% | -$59.3K | ﹤0.01% | 1576 |
|
|
2014
Q3 | $413K | Buy |
12,940
+12,860
| +16,075% | +$274K | ﹤0.01% | 1593 |
|
|
2014
Q2 | $2K | Hold |
80
| – | – | ﹤0.01% | 3577 |
|
|
2014
Q1 | $2K | Buy |
+80
| New | +$1.7K | ﹤0.01% | 3546 |
|
PNC Financial Services Group's AMAG Position: Q4 2020 in Review
PNC Financial Services Group sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 1,677 shares — an estimated $15K sold.
PNC Financial Services Group first reported a position in AMAG in Q1 2014 and held it in 27 quarters. The position peaked at $943K in Q2 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- PNC Financial Services Group reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- PNC Financial Services Group sold 1,677 AMAG Pharmaceuticals shares in Q4 2020, an estimated $15K.
- PNC Financial Services Group first reported a position in AMAG Pharmaceuticals in Q1 2014 and held it in 27 quarters.
- PNC Financial Services Group's AMAG Pharmaceuticals position peaked at $943K in Q2 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on PNC Financial Services Group's 13F filing for Q4 2020, filed 12 Feb 2021.